Live from the NIH registry
Studies recruiting near Fort Collins right now
Top 25 of 155 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
UCHealth Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: NRG Oncology
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Tekton Research - Longmont, CO — Longmont, Colorado (26.4 mi)
· Sponsor: Ardelyx
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Survivors Uniting for Remote Guided Exercise
Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
N/A
Interventional 300 participants sought
Human Performance Clinical Research Lab — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: National Cancer Institute (NCI)
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Mitral Annular Calcification, Mitral Stenosis
N/A
Interventional 210 participants sought
Uchealth Heart & Vascular Clinic Harmony Campus — Fort Collins, Colorado (2.8 mi)
· Sponsor: Mayra Guerrero
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (2.8 mi)
· Sponsor: AbbVie
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Emotion Management Skills, Lifestyle, Healthy
N/A
Interventional 200 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: soundBrilliance LLC
Countermeasures to Circadian Misalignment
Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease
N/A
Interventional 32 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: NRG Oncology
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Phase 3
Interventional 640 participants sought
Advanced Neurosciences Research, LLC — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Orthopaedic and Spine Center of the Rockies — Fort Collins, Colorado (2.8 mi)
· Sponsor: Exactech
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Generalized Myasthenia Gravis
Phase 3
Interventional 264 participants sought
Advanced Neurosciences Research LLC — Longmont, Colorado (26.4 mi)
· Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immunovant Sciences GmbH
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Advanced Neurology of Colorado — Fort Collins, Colorado (2.8 mi)
· Sponsor: Genentech, Inc.
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma
N/A
Observational 1,200 participants sought
Banner - MD Anderson Cancer Center - Northern Colorado — Greeley, Colorado (20.6 mi)
· Sponsor: M.D. Anderson Cancer Center
Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
Insulin Resistance, Depression
N/A
Interventional 300 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastroesophageal-junction Cancer, Monoclonal Antibody
Phase 3
Interventional 550 participants sought
Banner MD Anderson Cancer Center — Greeley, Colorado (20.6 mi)
· Sponsor: Shanghai Henlius Biotech